Ghyslaine Martel‐Planche

Author

Centre international de recherche sur le cancer

Also Known As

G Martel-Planche, G. Martel-Planche, Ghyslaine Martel-Planche, Ghyslaine Martel‐Planche

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Centre international de recherche sur le cancer Universidade Federal do Rio Grande do Sul Hospital de Clínicas de Porto Alegre AC Camargo Hospital Inserm

About

Ghyslaine Martel‐Planche is an author at Centre international de recherche sur le cancer specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	1.1K
2	Cell Biology	3	3	371
3	Natural Sciences	1	1	15
4	Public Health	1	1	145
5	Biochemistry	1	1	28

Ghyslaine Martel‐Planche

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms Virginie Marcel, Phong Lan Thao Tran, Charlotte Sagne, Carcinogenesis	2010	231
The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families Maria Isabel Achatz, Magali Olivier, Florence Le Calvez‐Kelm, Cancer Letters Tp53 MutationMendelian DisorderGenetic DisorderGeneticsGenetic Epidemiology	2006	210
p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers Monica Hollstein, Marie‐Jeanne Marion, Teresa A. Lehman, Carcinogenesis P53 MutationsOncogenic AgentMedicineP53 MutationPathology	1994	202
Detailed haplotype analysis at the<i>TP53</i>locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect Sonia Garritano, Federica Gemignani, Edenir Inêz Palmero, Human Mutation GeneticsHaplotype AnalysisGenetic EpidemiologyHuman PolymorphismPathology	2009	145
Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil Edenir Inêz Palmero, Lavínia Schüler‐Faccini, Maira Caleffi, Cancer Letters Breast OncologyCancer ScreeningMedicinePathologyBreast Cancer	2008	131
EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: Implications for anti‐EGFR treatment of a rare lung malignancy Antoîne Italiano, Alexis B. Cortot, Marius Ilié, International Journal of Cancer PathologyTumor BiologyOncologyRadiation OncologyRare Lung Malignancy	2009	112
<i>TP53</i> PIN3 and <i>MDM2</i> SNP309 polymorphisms as genetic modifiers in the Li–Fraumeni syndrome: impact on age at first diagnosis Virginie Marcel, Edenir Inêz Palmero, Priscila Falagan-Lotsch, Journal of Medical Genetics	2009	75
Inactivation of the p53 protein in cell lines derived from human esophageal cancers Christoph Barnas, Ghyslaine Martel‐Planche, Yoichi Furukawa, International Journal of Cancer	1997	71
<i>KRAS</i> mutation status in primary nonsmall cell lung cancer and matched metastases Alexis B. Cortot, Antoîne Italiano, Fanny Burel‐Vandenbos, Cancer	2010	64
Abnormal expression of the ATM and TP53 genes in sporadic breast carcinomas. Sandra Angèle, Isabelle Treilleux, Philippe Tanière, PubMed Breast OncologyImmunologyPathologyCancer BiologyTumor Biology	2000	57

Page 1